Comparison of the DANA to the ANAM in the Evaluation of Cognitive Changes After Concussion
Comparison of the Defense Automated Neurobehavioral Assessment (DANA) Brief Exam to the Automated Neuropsychological Assessment Metrics (ANAM) Battery in the Evaluation of Cognitive Changes During Concussion Recovery
1 other identifier
interventional
118
1 country
1
Brief Summary
The Defense Automated Neurobehavioral Assessment (DANA) was recently developed as a durable, portable, and "field-hardened" NeuroCognitive Assessment Tool. The purpose of this study is to compare the sensitivity of the DANA Brief exam with the Automated Neuropsychological Assessment Metrics (ANAM) battery currently used by the military after concussion. The primary hypothesis is that the DANA Brief exam will be more sensitive for detecting continued impaired cognitive performance than the ANAM during recovery after a concussion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2012
CompletedFirst Posted
Study publicly available on registry
November 16, 2012
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedOctober 6, 2017
October 1, 2017
1.6 years
November 13, 2012
October 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evidence of DANA Brief's improved sensitivity compared to ANAM
Outcome will be confirmed by the ability of the DANA Brief to detect statistically significant differences in cognitive performance between concussed and non-concussed groups even after the ANAM has indicated full recovery
within 10 days of injury
Study Arms (2)
Non-concussed
ACTIVE COMPARATORControl group; individuals assigned to this group will be either healthy volunteers or individuals sustaining an injury that does not involve concussion. Participants will take both the ANAM and DANA Brief twice at minimum.
Concussed
EXPERIMENTALIndividuals who have been diagnosed with a concussion by a clinician. Participants will take both the DANA and ANAM twice at minimum.
Interventions
The DANA Brief is a newly-developed neurocognitive test administered on a handheld computer that tests simple reaction time, procedural reaction time, code substitution, and spatial processing. The test also includes subtests for depression/distress, PTSD, and insomnia.
The ANAM is a currently used test by military health care providers in evaluating cognitive performance after concussion.
Eligibility Criteria
You may qualify if:
- Active-duty U.S. military service members
- Clinical diagnosis of concussion/mild traumatic brain injury (mTBI) (as defined by the American Congress of Rehabilitation, 1993, and DoD), made by the treating clinician based on clinical history, examination and/or clinical imaging performed as part of standard of care. This includes subjects with concussion from any mechanism (blast-related, blunt trauma etc.)--for concussed subjects only
- Glasgow Coma Scale (GCS) score of 15 as assessed by the consenting research staff--for concussed subjects only
- Concussive event that occurred within 72 hours of injury (to exclude service members presenting due to lingering effects of a previous injury)--for concussed subjects only
- Willingness to participate in the study, ability to communicate and comply with the study protocol and ability to provide informed consent.
You may not qualify if:
- Have a history of other mTBI within 90 days, moderate brain injury within the past 3 years, or any lifetime history of severe brain injury
- History of a documented diagnosis of post traumatic stress disorder (PTSD) or of treatment for PTSD
- Taking psychoactive medications, opioids, or other significant sedating medication
- Individuals with severe psychiatric disorders requiring continuing medication or recent treatment for an alcohol or drug dependency
- Report a pain level of 8 or greater on the 10-point Likert scale of 1 to 10 (e.g., 8, 9 or 10).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Concussion Restoration Care Center
Camp Leatherneck, Afghanistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jack Tsao, MD, DPhil
U.S. Navy Bureau of Medicine and Surgery (BUMED)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, TBI Programs
Study Record Dates
First Submitted
November 13, 2012
First Posted
November 16, 2012
Study Start
January 1, 2013
Primary Completion
August 1, 2014
Study Completion
August 1, 2014
Last Updated
October 6, 2017
Record last verified: 2017-10